Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
03/2004
03/31/2004EP1401831A1 Indazole benzimidazole compounds as tyrosine and serine/threonine kinase inhibitors
03/31/2004EP1401830A2 Quinazolinediones as antibacterial agents
03/31/2004EP1401828A1 N-formyl hydroxylamine compounds as inhibitors of pdf
03/31/2004EP1401826A1 Pyrazole derivatives as hiv reverse transcriptase inhibitors
03/31/2004EP1401820A1 5-ht receptor ligands and uses thereof
03/31/2004EP1401819A1 5-ht receptor ligands and uses thereof
03/31/2004EP1401817A1 Isoquinoline compounds having antiinfective activity
03/31/2004EP1401451A2 Quinazoline derivatives which promote the release of parathyroid hormone
03/31/2004EP1401431A2 Human growth hormone antagonists
03/31/2004CN1486312A Pyrazole compounds useful as protein kinase inhibitors
03/31/2004CN1486311A Pyrazole compounds useful as protein kinase inhibitors
03/31/2004CN1486310A Pyrazole compounds useful as protein kinase inhibitors
03/31/2004CN1486309A Tetrahydroazepine derivatives useful as dopamine d3 receptor modulators (antipsychotic agents)
03/31/2004CN1486308A Piperazinylcarbonylquinolines and -isoquinolines
03/31/2004CN1143856C Novel substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl) [1,4] diazepan-1-yl)-1-(aryl) butyl) benzamides useful for treatment of allergic diseases
03/31/2004CN1143854C Novel 2-(iminomethyl) amino-phenyl derivatives,the preparation thereof, application as medicines and pharmaceutical compositions containing same
03/31/2004CN1143675C Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics
03/30/2004US6713635 As chemical intermediates used for the preparation of s-alpha-ethyl-2-oxo-1-pyrrolidine acetamide
03/30/2004US6713631 Preparation method of 2,2'-bi-1H-imidazole using glyoxal and an ammonium salt
03/30/2004US6713603 Adjusted nucleotide sequences for use as antisense tools in genetic engineering
03/30/2004US6713502 Anti-infectives
03/30/2004US6713496 3-(imidazolyl)-2-alkoxypropanoic acids
03/30/2004US6713487 Heterocyclic amine derivatives; for treating an inflammatory or immune disease, a cardiovascular disease, or a neurodegenerative condition
03/30/2004US6713482 Such as (e)-1-(2-pyridyl)-2-styryl-1h-benzimidazole; antiinflammatory and analgesic agents; prostaglandin inhibitors
03/30/2004US6713480 Phenylahistin and the phenylahistin analogs, a new class of anti-tumor compounds
03/30/2004US6713473 6-carbamate-1,2,3,4-tetrahydrocarbazole derivatives; affinity for neuropeptide y receptors
03/30/2004US6713472 Thiazine or pyrazine derivatives
03/30/2004US6713461 Eletriptan and sulphobutylether-beta-cyclodextrin; well tolerated intranasal delivery; bioavailability; fast acting
03/30/2004US6713436 1-cycloalkylpyrazolyl-benzoyl derivatives
03/30/2004CA2194502C 2-[1',2',4'-triazol-3'-yloxymethylene]anilides, their preparation and their use
03/30/2004CA2067924C N-alkylenepiperidino compounds and their enantiomers, process for preparing them and pharmaceutical compositions containing them
03/25/2004WO2004024722A1 Tetrahydropyridazine derivatives having a pesticidal effect
03/25/2004WO2004024721A1 Hydantoin derivatives und deren verwendung als tace inhibitoren
03/25/2004WO2004024720A1 Piperazine urea derivatives as melanocortin-4 receptor agonists
03/25/2004WO2004024716A1 Process for producing cilostazol
03/25/2004WO2004024715A1 Sulphonamide derivatives and their use as tace inhibitors
03/25/2004WO2004024710A1 Urea compounds active as vanilloid receptor antagonists for the treatment of pain
03/25/2004WO2004024702A1 Novel carboxamide compounds having an mch-antagonistic effect, medicaments containing said compounds, and methods for the production thereof
03/25/2004WO2004024701A1 Heterocyclic derivatives
03/25/2004WO2004024700A1 Pyrimidinone derivatives as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes
03/25/2004WO2004024699A1 Benzimidazolones and their use as cytokine inhibitors
03/25/2004WO2004024697A1 Amine compounds and use thereof
03/25/2004WO2004024162A1 2-amino-4-quinazolinones as lxr nuclear receptor binding compounds
03/25/2004WO2004024161A1 Novel 2-amino-4-oxoquinazolones as lxr nuclear receptor binding compounds with partial agonistic properites
03/25/2004WO2004024140A1 Efflux pump inhibitors
03/25/2004WO2004004665A3 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
03/25/2004WO2003104207A3 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
03/25/2004WO2003090680A3 Novel phenyl derivatives as inducers of apoptosis
03/25/2004WO2003086318A3 Improved prodrugs of cc-1065 analogs
03/25/2004WO2003086306B1 5ht2c receptor modulators
03/25/2004WO2003086287A3 Compounds and methods for inducing apoptosis in proliferating cells
03/25/2004WO2003082186A3 Use of benzimidazole analogs in the treatment of cell proliferation
03/25/2004WO2003074523A3 Gadolinium chelate oligomers, their use as contrast products in magnetic resonance imaging and their synthesis intermediates
03/25/2004WO2003051846A3 Substituted phenyl derivatives
03/25/2004WO2003051366A3 3-(phenyl-alkoxy)-5-(phenyl)-pyridine derivatives and related compounds as kinase inhibitors for the treatment of cancer
03/25/2004WO2003027081A3 NOVEL LIGANDS FOR THE HisB10 Zn2+ SITES OF THE R-STATE INSULIN HEXAMER
03/25/2004US20040059132 Reacting an indolin-2-one derivative with substituted benzyl halide to form substituted N-benzyl indolin-2-one derivatives have an affinity for oxytocin receptors
03/25/2004US20040059113 Such as 3-(1-(2-hydroxyethyl)-1H-indol-3-yl)-4-(1-(3-pyridinyl)-1H-indol-3-yl)-1H -pyrrole-2,5-dione
03/25/2004US20040058980 Useful aroyl pyrrole heteroaryl methanones and methanols
03/25/2004US20040058978 Novel substituted indolines with an inhibitory effect on various kinases and complexes of CDKs
03/25/2004US20040058965 Alkanoic acid derivatives process for their production and use thereof
03/25/2004US20040058960 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
03/25/2004US20040058942 Substituted dihydropyrimidines, dihydropyrimidones and dihydropyrimidinethiones as calcuim channel blockers
03/25/2004US20040058941 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
03/25/2004US20040058937 Heterocyclic mutilin esters and their use as antibacterials
03/25/2004US20040058934 Heterocyclic compounds
03/25/2004US20040058933 Aryl carbamate derivatives, preperation and use thereof
03/25/2004US20040058932 Novel piperazine derivatives
03/25/2004US20040058916 Central nervous system disorders; psychological disorders; schizophrenia; antiarthritic agents; Alzheimer's disease; anticancer agents
03/25/2004US20040058913 Cyclic diamine compound with condensed-ring groups
03/25/2004US20040058912 Psychological disorders; eating disorders; dietetics
03/25/2004CA2498655A1 2-amino-4-quinazolinones as lxr nuclear receptor binding compounds
03/25/2004CA2498272A1 Piperazine urea derivatives as melanocortin-4 receptor agonists
03/25/2004CA2497571A1 Hydantoin derivatives and their use as tace inhibitors
03/25/2004CA2496563A1 New carboxamide compounds having mch-antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture
03/24/2004EP1400522A1 New compounds for treating impotence
03/24/2004EP1400518A1 Heterocyclic compound derivatives and medicines
03/24/2004EP1400515A1 Cyclic diamine compound having five-membered cyclic group
03/24/2004EP1400510A1 Cyclic diamine compounds having fused-ring groups
03/24/2004EP1400241A1 Fused cyclic compounds and medicinal use thereof
03/24/2004EP1399441A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists
03/24/2004EP1399439A1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases
03/24/2004EP1399436A2 Oxytocin agonists
03/24/2004EP1399434A1 Novel indole derivatives
03/24/2004EP1399433A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
03/24/2004EP1399431A2 Novel nitriles useful as reversible inhibitors of cysteine proteases
03/24/2004EP1399428A1 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines as crf1 receptor modulators
03/24/2004EP1399420A2 Pyrrolidines as dipeptidyl peptidase inhibitors
03/24/2004EP1399156A2 Alkylidene pirazolidinedione derivatives and their use for treating diabetes and obesity
03/24/2004EP1399154A1 3-fluoro-pyrrolidines as antidiabetic agents
03/24/2004EP1399117A1 Dyeing composition for keratinous fibres comprising a particular dicationic diazo dye
03/24/2004EP1399116A1 Use of dicationic compounds for dyeing human keratinous fibres and compositions containing same
03/24/2004EP1280796B1 Pyrimidinyl methyl indole derivatives with antibacterial activity
03/24/2004EP1197493B1 Benzimidazole compounds
03/24/2004EP1131318B1 Process for making 5-substituted pyrazoles using dithietanes
03/24/2004EP1117641B1 Indolin derivatives as sun protection agents
03/24/2004EP1097150B1 Imidazolyl derivatives
03/24/2004EP1047690B1 Heterocyclic ether and thioether compounds useful in controlling chemical synaptic transmission
03/24/2004EP0922036B1 Arylalkanoyl pyridazines
03/24/2004CN1484640A Quinzolone derivatives as alpha IA/B adrenergic receptor antagonists